π
|
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
46 auth.
B. Chapuy,
C. Stewart,
Andrew J. Dunford,
Jaegil Kim,
A. Kamburov,
R. Redd,
Mike S. Lawrence,
M. Roemer,
Amy Li,
M. Ziepert,
A. Staiger,
J. Wala,
M. Ducar,
I. Leshchiner,
Ester Rheinbay,
...
A. Taylor-Weiner,
C. Coughlin,
J. Hess,
C. Pedamallu,
D. Livitz,
D. Rosebrock,
Mara W Rosenberg,
A. Tracy,
H. Horn,
P. Van Hummelen,
A. Feldman,
B. Link,
A. Novak,
J. Cerhan,
T. Habermann,
R. Siebert,
A. Rosenwald,
A. Thorner,
M. Meyerson,
T. Golub,
R. Beroukhim,
G. Wulf,
G. Ott,
S. Rodig,
S. Monti,
D. Neuberg,
M. Loeffler,
M. Pfreundschuh,
L. TrΓΌmper,
G. Getz,
M. Shipp
|
10 |
2018 |
10 π
|
π
|
Nivolumab for classical Hodgkin lymphoma after autologous stem-cell transplantation and brentuximab vedotin failure: a prospective phase 2 multi-cohort study
21 auth.
A. Younes,
A. Santoro,
M. Shipp,
P. Zinzani,
J. Timmerman,
S. Ansell,
P. Armand,
M. Fanale,
V. Ratanatharathorn,
J. Kuruvilla,
...
Jonathon B. Cohen,
G. Collins,
K. Savage,
M. TrnΔnΓ½,
Kazunobu Kato,
B. Farsaci,
S. Parker,
S. Rodig,
M. Roemer,
A. Ligon,
A. Engert
|
9 |
2016 |
9 π
|
π
|
PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
11 auth.
Benjamin J Chen,
B. Chapuy,
Ouyang Jing,
Heather H. Sun,
M. Roemer,
Mina L. Xu,
...
Hongbo Yu,
C. Fletcher,
G. Freeman,
M. Shipp,
S. Rodig
|
9 |
2013 |
9 π
|
π
|
Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.
16 auth.
B. Chapuy,
M. Mckeown,
Charles Y. Lin,
S. Monti,
M. Roemer,
J. Qi,
P. Rahl,
Heather H. Sun,
Kelly T. Yeda,
John G Doench,
...
Elaine Reichert,
A. Kung,
S. Rodig,
R. Young,
M. Shipp,
J. Bradner
|
9 |
2013 |
9 π
|
π¦
|
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.
17 auth.
M. Roemer,
R. Advani,
A. Ligon,
Y. Natkunam,
R. Redd,
H. Homer,
Courtney F Connelly,
Heather H. Sun,
S. Daadi,
G. Freeman,
...
P. Armand,
B. Chapuy,
D. de Jong,
R. Hoppe,
D. Neuberg,
S. Rodig,
M. Shipp
|
9 |
2016 |
9 π¦
|
π
|
Targetable genetic features of primary testicular and primary central nervous system lymphomas.
31 auth.
B. Chapuy,
M. Roemer,
C. Stewart,
Yuxiang Tan,
R. Abo,
Liye Zhang,
Andrew J. Dunford,
David M. Meredith,
A. Thorner,
E. Jordanova,
Gang Liu,
F. Feuerhake,
M. Ducar,
G. Illerhaus,
D. Gusenleitner,
...
Erica A Linden,
Heather H. Sun,
H. Homer,
Miyuki Aono,
G. Pinkus,
A. Ligon,
K. Ligon,
J. Ferry,
G. Freeman,
P. Van Hummelen,
T. Golub,
G. Getz,
S. Rodig,
D. de Jong,
S. Monti,
M. Shipp
|
8 |
2014 |
8 π
|
π
|
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma.
9 auth.
L. Nayak,
F. Iwamoto,
A. LaCasce,
S. Mukundan,
M. Roemer,
B. Chapuy,
...
P. Armand,
S. Rodig,
M. Shipp
|
8 |
2017 |
8 π
|
π¦
|
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
29 auth.
M. Roemer,
R. Redd,
F. Cader,
Christine J. Pak,
Sara Abdelrahman,
Ouyang Jing,
S. Sasse,
A. Younes,
M. Fanale,
A. Santoro,
P. Zinzani,
J. Timmerman,
G. Collins,
R. Ramchandren,
Jonathon B. Cohen,
...
J. D. de Boer,
J. Kuruvilla,
K. Savage,
M. TrnΔnΓ½,
S. Ansell,
Kazunobu Kato,
B. Farsaci,
A. Sumbul,
P. Armand,
D. Neuberg,
G. Pinkus,
A. Ligon,
S. Rodig,
M. Shipp
|
8 |
2018 |
8 π¦
|
π
|
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma.
16 auth.
Christopher D. Carey,
Christopher D. Carey,
D. Gusenleitner,
M. Lipschitz,
M. Roemer,
M. Roemer,
E. Stack,
E. Gjini,
Xihao Hu,
R. Redd,
...
G. Freeman,
D. Neuberg,
F. Hodi,
Xiaole Shirley Liu,
M. Shipp,
S. Rodig
|
8 |
2017 |
8 π
|
π
|
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma.
16 auth.
Christopher D. Carey,
Christopher D. Carey,
D. Gusenleitner,
M. Lipschitz,
M. Roemer,
M. Roemer,
E. Stack,
E. Gjini,
Xihao Hu,
R. Redd,
...
G. Freeman,
D. Neuberg,
F. Hodi,
Xiaole Shirley Liu,
M. Shipp,
S. Rodig
|
8 |
2017 |
8 π
|
π
|
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.
18 auth.
S. Ansell,
M. Minnema,
P. Johnson,
J. Timmerman,
P. Armand,
M. Shipp,
S. Rodig,
A. Ligon,
M. Roemer,
N. Reddy,
...
Jonathon B. Cohen,
S. Assouline,
M. Poon,
M. Sharma,
Kazunobu Kato,
S. Samakoglu,
A. Sumbul,
A. Grigg
|
8 |
2019 |
8 π
|
π¦
|
Classical Hodgkin Lymphoma with Reduced Ξ²2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status
16 auth.
M. Roemer,
R. Advani,
R. Redd,
G. Pinkus,
Y. Natkunam,
A. Ligon,
Courtney F Connelly,
Christine J. Pak,
Christopher D. Carey,
S. Daadi,
...
B. Chapuy,
D. de Jong,
R. Hoppe,
D. Neuberg,
M. Shipp,
S. Rodig
|
7 |
2016 |
7 π¦
|